https://doi.org/10.55788/3366f978
A systematic review of 55 trials totalling more than 4,500 participants with psoriasis concluded that a hypocaloric diet should be recommended in people with psoriasis who are overweight or obese [2]. A gluten-free diet could be recommended in people who have concomitant confirmed coeliac disease or a positive serology for gluten sensitivity. Low-quality observational evidence also showed that Mediterranean diets could be effective, but well-designed clinical trials are needed to confirm this conclusion.
A more recent meta-analysis analysed the effect of dietary interventions in obese participants on psoriasis outcomes, including 6 randomised controlled trials [3]. Dietary intervention (strict caloric restriction) compared with usual care led to reductions in Psoriasis Area and Severity Index (PASI) scores at week 16 (very low-quality intervention). In 2 of these trials, dietary intervention also improved quality-of-life (moderate quality evidence). Furthermore, the combination of diet intervention plus exercise programme compared with information only led to reductions in BMI and higher proportions of participants achieving ≥50% reduction in PASI (moderate quality evidence), but not with achieving ≥75% reduction in PASI.
Prof. Hall continued by describing 2 studies that assess dietary associations with psoriasis [1]. The APPLE study (NCT05448352) is an online, cross-sectional survey collecting data on psoriasis severity, diet, demographics, and lifestyle characteristics. Dietary intakes were measured using the EPIC Food Frequency Questionnaire. In total, 371 participants started the APPLE survey and 270 participants completed the study. The recruited population were mainly White, British, women, and non-smoking with a median age of 40 years. The dietary intake of fibres, fatty acids, and sugars was similar to the overall British population. Overall, 51% of participants were comorbid obese or overweight and 19% had cardiometabolic disease. Regression analyses showed that increasing diet scores were associated with lowered psoriasis severity (P<0.05). For the Mediterranean Diet Score, intake of meat and poultry were positive predictors for psoriasis severity (P<0.05) and intake of fruits, nuts, and legumes were negative predictors of severity (P<0.05).
The METRED-P (NCT05820698) study aims to evaluate the feasibility of implementing a Mediterranean-style diet and/or time-restricted eating as dietary patterns for individuals with psoriasis, with a BMI of 25–50 who were not receiving phototherapy or systemic therapy. The trial will assess adherence to the dietary intervention as well as measures of psoriasis.
In summary, “diet quality is associated with psoriasis severity,” said Prof. Hall [1]. “The work done so far will generate hypotheses for potential dietary targets, possibly including plant-based diets. Ultimately we hope this will lead to evidence-based dietary guidelines for psoriasis management.”
- Hall W. Impact of lifestyle interventions in psoriatic disease. IFPA Conference 2024, 27–29 June, Stockholm, Sweden.
- Ford AR, et al. JAMA Dermatol. 2018;154(8):934-950.
- Ko SH, et al. Cochrane Database Syst Rev. 2019;7(7):CD011972.
Copyright ©2024 Medicom Medical Publishers
Posted on
Previous Article
« Biologics in psoriatic arthritis: where we are and where we are headed Next Article
Itch and pain are major components of psoriatic disease and require management »
« Biologics in psoriatic arthritis: where we are and where we are headed Next Article
Itch and pain are major components of psoriatic disease and require management »
Table of Contents: IFPA 2024
Featured articles
Multiple novel oral agents show promise in psoriasis
Advances in psoriasis treatment: topical therapies show promising results
Personalised Medicine and Genetics in Psoriatic Disease
How close are we to personalised medicine in psoriatic arthritis?
Genetic and immunological advances in risk assessment and treatment of psoriatic diseases
Using advances in the genetics of psoriatic disease to better predict treatment response
Comorbidities and Complications in Psoriatic Disease
Depression complicates the management of psoriatic disease
The unfavourable role of obesity in psoriatic disease
Managing obesity and fibromyalgia in psoriatic disease
Advances in Psoriasis Treatment
Multiple novel oral agents show promise in psoriasis
Biologics for psoriasis: towards oral therapies and less frequent dosing
Advances in psoriasis treatment: topical therapies show promising results
Special Populations and Psoriatic Disease
Improving outcomes in pregnancy and psoriatic disease
Towards prevention of psoriatic arthritis in patients with psoriasis
Diagnostic Challenges and Disease Management
Itch and pain are major components of psoriatic disease and require management
Can diet help with the management of psoriasis?
Biologics in psoriatic arthritis: where we are and where we are headed
Related Articles
February 2, 2022
Selective IL-23 inhibition normalises gene expression in active PsA
February 4, 2020
Psoriasis onset determines sequence of symptoms
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com